Abstract-Store-operated calcium (SOC) entry is sufficient to disrupt the extra-alveolar, but not the alveolar, endothelial cell barrier. 
ndothelium is remarkably diverse, with significant structural and functional heterogeneity apparent between organs, along vascular segments, and indeed, within immediately adjacent cells. Relatively little is known about how such diversity is maintained, and how site-specific responses are determined. Transitions in cytosolic calcium ([Ca 2ϩ ] i ) fulfill important signaling roles in endothelium, including the dynamic regulation of interendothelial cell gap formation that increases water, solute, and protein permeability. However, Ca 2ϩ entry specifically through store-operated channels provides a [Ca 2ϩ ] i source that is sufficient to increase permeability across a subset of macrovascular, but not across microvascular, endothelial cells. [1] [2] [3] Similarly, activation of storeoperated calcium (SOC) entry increases macrovascular but not microvascular endothelial cell permeability in the intact pulmonary circulation. 4, 5 Although microvascular endothelial cells possess enhanced cell-cell adhesion compared with their macrovascular counterparts, 1, 6 the mechanism for their relative insensitivity to rises in [Ca 2ϩ ] i are not known. We previously reported that the activation of SOC entry results in a smaller [Ca 2ϩ ] i transition in pulmonary microvascular endothelial cells (PMVECs) than in pulmonary artery endothelial cells (PAECs). 7 A more depolarized membrane potential, increased Ca 2ϩ extrusion, and/or decreased Ca 2ϩ entry could all account for the decreased PMVEC [Ca 2ϩ ] i response to thapsigargin. Evidence among different cell types illustrates that thapsigargin activates multiple ion channels, which differ in their biophysical characteristics, including ion selectivity. 8 -10 For example, thapsigargin activates both Ca 2ϩ -selective [11] [12] [13] [14] [15] and nonselective 16 -18 cationic conductances in endothelial cells, although this work has routinely been performed using cells of conduit origin (eg, pulmonary artery, aorta, and human umbilical vein) and not from the microcirculation. Therefore, it is not known whether thapsigargin activates similar Ca 2ϩ -selective and nonselective conductances in PAECs and PMVECs.
There is reason to suggest that macro-and microvascular endothelial cells do not express similar ion channels, or similar regulatory mechanisms, based partly on their distinct phenotypes and functions. Functional differences between macro-and microvascular endothelial cells are evident early in development, and transmissible through mitotic divisions into adulthood. 19 Our present studies therefore sought to determine whether PAECs and PMVECs possess different SOC entry pathways and, further, to identify which Ca 2ϩ entry pathway controls interendothelial cell gap formation.
Materials and Methods
Isolation and culture of rat lung endothelial cells. Endothelial cells were isolated and cultured as described. 20 
In Vitro Fluorescence Measurements
All fluorescence measurements were conducted using an SLM-AMINCO Model 8100 high-resolution spectrofluorometer and a 10-mm pathlength cell at Ϸ23°C. Initial spectra bandwidth and wavelength calibrations were performed using an NIST-traceable fluorescence intensity set (Wilmad Glass; cat. no. 921-1). Excitation and emission spectra were acquired using a 4-nm bandpass throughout the optical paths, with a spectral scan rate of 0.95 nm⅐sec Ϫ1 and integration time 1.0 second, in a toggled-excitation mode (to minimize photobleaching).
In Vitro Fura-2 Dye and Cation Measurements
All solutions were prepared using analytical-grade reagents, in Ͼ18 M⍀ quality Type I water. Divalent salts (cation 2 Cl Ϫ ; Be 2ϩ , Mg 2ϩ , Ca 2ϩ , Sr 2ϩ , Ba 2ϩ ) and LaCl 3 (Aldrich Chemical) solutions were prepared as 10 mmol/L solutions in 1 mol/L pluronic acid containing K ϩ Ringers buffer, both in the absence and presence of 100 nmol/L Ca 2ϩ . Fura-2 pentasodium salt (Molecular Probes) was prepared as per instructions.
Molecular Modeling
Molecular mechanics, semiempirical, and ab initio calculations using Spartun '02 (Wavefunction, Inc) were performed on a Dell 8200 (2.4-GHz Pentium 4) computer. The restricted Hartree-Fock SCF ab initio calculations used the 6-31G(d) basis set, which includes polarization functions, recommended for the description of heavy atoms in medium/large sized systems. The 6-31G(d) basis set was used for the initial ground-state molecular structure optimization. The default grid option was chosen for numerical integration of matrix elements. The 6-31G(d) basis set involved a total of 242 electrons with 238 contracted Gaussian basis functions consisting of 744 primitive Gaussians. The optimized parent ab initio structure was used as a basis for all subsequent molecular mechanics and semiempirical calculations. For all models, C 1 symmetry was used throughout full optimization and subsequent frequency calculations. Analytical harmonic vibrational frequencies were computed for all structures to confirm that local minima on the potential energy surface had been found. PM3 (Parameterized Model, revision 3) semiempirical and MMFF94 (Merck Pharmaceutical Force Field) molecular mechanics calculations were compared as applicable in the metal-ion complexed species. For Be 2ϩ , a tetrahedral binding complex association was used; for all other 2ϩ and 3ϩ cations, octahedral binding complex associations were assumed.
Cytosolic Cation Measurements
Cytosolic Ca 2ϩ was estimated using fura 2/acetoxymethylester (Molecular Probes) according to methods previously described. 13, 14, 18, 21 
Patch Clamp Electrophysiology
Conventional whole-cell voltage-clamp configuration was performed to measure transmembrane currents in single rat PAEC or PMVEC by the standard giga-seal patch-clamp technique, as described. 14, 15 
TRPC4 Expression in Endothelial Cells
PMVEC monolayers were lysed in hypotonic buffer, and membrane/ cytoskeleton fractions prepared via differential centrifugation and homogenization. These fractions were extracted in Triton X-100 detergent containing 100 mmol/L potassium iodide and centrifuged at 145 000g (50 minutes, 4°C) to yield an insoluble pellet and soluble supernatant. Pellet and supernatant samples were subjected to SDS-PAGE and transferred to nitrocellulose membranes. Membranes were rocked with primary antibody to TRPC4 (gift from M. Zhu, The Ohio State University, Columbus, Ohio) and horseradish peroxidase tagged secondary antibody. Proteins were visualized via enhanced chemiluminescence detection.
Time-Lapse Microscopy
Cells were grown to confluence on 25-mm glass coverslips, placed on the microscope stage, and imaged (40ϫ oil immersion) at 1-minute intervals for approximately 2 hours using Metamorph and Spot Software (Diagnostic Instruments). Rolipram (10 mol/L) was applied to monolayers for 16 minutes before application of thapsigargin (1 mol/L), as indicated. 22 
Isolated Perfused Lung Experiments
Heart and lungs were removed en bloc from adult CD40 rats (approximately 300 to 400 g), suspended in a humidified environment, ventilated, and perfused as previously. 22 
Methyl Methacrylate Casting Experiments
Lungs were isolated from anesthetized SD40 rats and endothelial permeability measured via Kf as described. Casting material was prepared as described by Gannon. 23 Methyl methacrylate was prepolymerized under UV light (312 nm) to achieve a viscosity of 2.4 cPs, a viscosity that has been shown to be optimal for identification of endothelial leaks. 4 After baseline measurements, lungs were treated for 20 minutes with either vehicle (DMSO 18 L, nϭ4) or rolipram (10 mol/L, nϭ3) followed by 20 minutes perfusion with thapsigargin (100 nmol/L), and a final Kf measured. Venous pressure was raised by Ϸ8 cmH 2 O from baseline, and prepolymerized methyl methacrylate was combined with benzoyl peroxide, OH-propyl methacrylate, and N-NЈ-dimethyl aniline, and infused into the pulmonary circulation at a constant flow. After complete polymerization (Ϸ1 hour after casting material infusion) successive corrosion of the lung casts was initiated and maintained over 3 weeks with alternating HCl and KOH (5 mol/L each). The casts were fragmented to expose the internal vascular architecture and specimens were mounted on aluminum stubs, coated with gold palladium, and examined using SEM (Philips XL 20, FEI). Pulmonary endothelial injury was determined by the appearance of blebs at the casting surface, which represent areas of endothelial leaks. 4 
Results

SOC Entry in PAECs and PMVECs
PAECs exhibit increased global [Ca 2ϩ ] i responses to thapsigargin when compared with PMVECs, although the mechanism accounting for this difference is not clear. Figure 1 demonstrates the typical [Ca 2ϩ ] i response to a near-maximal ] i response in PAECs was greater than it was in PMVECs. Representative trace shows results similar to those previously published elsewhere. 1, 7 thapsigargin (1 mol/L; EC 95 ) concentration in both cell types, illustrating an approximate 50% lower [Ca 2ϩ ] i rise in PMVECs. 7 Thapsigargin activates a number of ion channels in endothelial cells, including channels that are selective and nonselective for Ca 2ϩ . 18 Recently, Zweifach 24 developed a furabased approach to evaluate ion permeability through SOC entry channels, using the recalcification protocol, allowing for discrimination between Ca 2ϩ -selective and nonselective channels in living cells. To ascertain cation-induced influx in living cells, cation-fura interactions were investigated by high-resolution fluorescence spectroscopy in physiological salt solutions, in the presence and absence of 100 nmol/L Ca 2ϩ . The ex-max for Be 2ϩ , Ca 2ϩ , Ba 2ϩ , Sr 2ϩ , and La 3ϩ in the absence of Ca 2ϩ was 354, 310, 320, 317, and 316 nm, respectively. The optimal em-max for all divalent cations in Ca 2ϩ free buffer was 502Ϯ8 nm. Individual spikes were obtained by sequential irradiation at 340 and 380 nm, respectively, and the intensity ratios compared with nonspiked Ca 2ϩ containing buffer. These experiments revealed a minor competition by 100 nmol/L Ca 2ϩ for fura-2 binding sites in the series Ba 2ϩ , Sr 2ϩ , and La 3ϩ . However, Ca 2ϩ competed strongly against Be 2ϩ , resulting in an approximate 60% decrease in the 340-nm signal and a 4% increase in the 380-nm signal vis-à-vis other cations 2ϩ␤ϩ . We performed molecular modeling experiments to ascertain structural differences between fura-Be 2ϩ and other furacation 2ϩ␤ϩ that may account for the measurable difference in complex excitation wavelengths. The uncomplexed fura ground state structure resembles a glove-like pocket with preferential cation 2ϩ␤ϩ binding to the carboxylates extending from the 5-carboxy-oxazolyl and one of the N-acetyl-5-methylphenoxy moieties, respectively ( Figure 2 ). In the fura-2-cation complexes involving Ca 2ϩ , Mg 2ϩ , Sr 2ϩ , and La 3ϩ , a relatively planar extended -conjugated network involving the oxazolyl-and benzofuranyloxy-rings were observed, with minor deviance from overall planarity (0.68°). However, Be 2ϩ complexation significantly distorted the fura conjugated network (25.32°), shifting the excitation spectra. Indeed, the molecular backbone in the fura-Be 2ϩ complex is distorted from planarity (twisted Figure 3B ).
To establish relative permeability ratios to divalent cations in PAECs and PMVECs, thapsigargin-induced cation entry was compared with digitonin-induced cation entry. 24 Digitonin permeabilizes cell membranes and thus promotes cation equilibration between extracellular and intracellular compartments. Digitonin did not stimulate Ca 2ϩ release from intracellular stores ( Figure 3C) nonselective channels more efficiently in PAECs or, alternatively, thapsigargin activates a Ca 2ϩ -selective entry pathway in PAECs that is not activated in PMVECs. La 3ϩ permeates ion channels and can inhibit Ca 2ϩ entry by an "intracellular" block, 25 perhaps because the effective ionic radii of the solvated octahedrally coordinated ions are remarkably similar (Ca 2ϩ ϭ1.00 Å; La 3ϩ ϭ1.05 Å). 26 This size similarity is a consequence of the well-known "lanthanide contraction," ie, the poor shielding by the outer valence electrons in the 4th and 5th subshell levels results in an increase in the effective nuclear charge and thus a concomitant reduction in ionic size. 27 We investigated thapsigarginactivated La 3ϩ permeability and compared this permeability to Ca 2ϩ . La 3ϩ permeability was equal in PAECs (0.28) and PMVECs (0.27) (Figure 4 ) and was nearly identical to the Ca 2ϩ permeability observed in PAECs (0.28). However, in PMVECs, La 3ϩ permeability was higher than that of Ca 2ϩ , suggesting La 3ϩ influx occurs through a Ca 2ϩ impermeable pore or, alternatively, that it more readily accesses a Ca 2ϩ permeable pore. Ion-water interaction is an important determinant of ion permeability through the pores of ion channels, 28, 29 where water is excluded from the channel's internal pore. To the extent that the ions are solvated in an aqueous medium, it has been suggested that ion-water complexes are most stable when the electronegativity of the water ligands was such that the cation achieved an essentially neutral condition (electroneutrality principle). 30 , and La 3ϩ all form stable octahedral aqueous complexes. Qualitatively, the degree of hydration of a metal complex mediates the availability of electron density and resultant ionic charge of the metal centers themselves. Although the solvated ion-complex has a net formal charge of either ϩ2 (Ca 2ϩ ) or ϩ3 (La 3ϩ ), the net positive charges are dispersed over the twelve hydrogen atoms of the solvated complexes. The removal of water ligands as the ion is desolvated for passage through the ion pore, and resolvated on intracellular entry, introduces complex charge interactions between the free ion and the transmembrane protein amino acids themselves. La 3ϩ that dissociates from water as it enters the ion pore may have more favorable charge-contact interactions and charge stabilization and thus permeate a partially closed or inactivated channel more readily than would Ca 2ϩ . This suggests that La 3ϩ may more readily access a Ca 2ϩ permeable pore in PMVECs.
I SOC Activation in Endothelial Cells
Conduit endothelial cells possess a thapsigargin-activated Ca 2ϩ -selective current, I SOC . [13] [14] [15] We therefore sought to determine whether the decrease in thapsigargin-induced Ca replenished to the extracellular media. La 3ϩ entry through SOC entry channels was similar between PAECs and PMVECs. B, La 3ϩ entry was also similar in PAECs and PMVECs after membrane permeabilization using digitonin (1 mol/L). permeability in PMVECs resulted from an apparent absence of I SOC . I SOC activation requires interaction between spectrin and protein 4.1. 15 Figure 5A illustrates, as in our earlier studies, 15 that disruption of the spectrin-protein 4.1 interaction, done by using a spectrin antibody SG921 that specifically targets on protein 4.1 binding domain on spectrin, reduces the global [Ca 2ϩ ] i response to thapsigargin by approximately 40% in PAECs. However, disruption of the spectrinprotein 4.1 interaction did not alter the global [Ca 2ϩ ] i response to thapsigargin in PMVECs ( Figure 5B ). Superimposition of thapsigargin-induced [Ca 2ϩ ] i responses from PAECs after disruption of spectrin-protein 4.1 binding and "normal" PMVECs revealed an exact overlay ( Figure 5C ), suggesting microvascular endothelial cells lack I SOC . To address this issue further, thapsigargin was applied to single PAECs and PMVECs in a conventional whole-cell configuration using solutions previously described. 14, 15 In PAECs, thapsigargin activated an inward Ca 2ϩ current (approximately 60 pA on average) that reversed near ϩ40 mV and was inwardly rectifying ( Figure 5D ). In PMVECs, thapsigargin did not activate an inward current despite repeated efforts ( Figure  5E ), again suggesting microvascular endothelial cells lack I SOC .
Endothelial cells isolated from TRPC4-deficient mice lack I SOC , 32 and antisense inhibition of TRPC1 reduces I SOC . 14 These findings have been taken as support for the idea that TRPC1 and TRPC4 proteins form-at least in part-the molecular basis of I SOC channels in endothelial cells. 13, 14 If this idea is correct and PMVECs lack I SOC , then these cells should not express TRPC1 or TRPC4. We examined TRPC4 expression in PMVECs and found it to be prominently expressed, to levels resembling its expression in PAECs ( Figure 6A) . As in our studies using PAECs, the PMVEC TRPC4 channel is physically associated with protein 4.1 and spectrin (data not shown). Thus, it appears PMVECs possess the molecular machinery necessary to activate I SOC .
The type 6 calcium-inhibited adenylyl cyclase, AC6, is expressed in both PAECs and PMVECs. Although submicromolar calcium concentrations inhibit AC6 activity in membranes isolated from both cell types, 33, 34 calcium inhibition of whole-cell cAMP is difficult to resolve in PMVECs. 18, 33 Preincubation of PMVECs with rolipram elevates cAMP dramatically, and unmasks calcium inhibition of cAMP synthesis. 33 We therefore questioned whether rolipram reveals a thapsigargin-activated I SOC , providing the calcium source that regulates AC6 activity. Rolipram treatment unmasked the I SOC current in PMVECs ( Figure 6B ), suggesting I SOC channels exist near AC6 and importantly control enzyme activity. However, rolipram treatment abolished I SOC in PAECs ( Figure 6C ), underscoring the distinct role of phosphodiesterase 4 in regulating membrane cAMP concentrations, and actions, in PAECs and PMVECs.
I SOC in Control of PMVEC Permeability SOC entry is sufficient to induce gaps in endothelial cells derived from conduit vessels, but not in endothelial cells isolated from the microcirculation. 1, 5 We questioned whether the absence of I SOC in PMVECs contributes to their insensitivity to thapsigargin. Figure 7A and the accompanying time-compressed video shows the stable junctional apposition in PMVECs (see Online Movies 1 and 2 in the online data supplement available at http://circres.ahajournals.org). However, pretreatment with rolipram reveals thapsigargin-induced gap formation, consistent with the idea that Ca 2ϩ permeation through I SOC channels disrupt cell-cell and cell-matrix tethering and increase centripetally directed tension sufficient to form an intercellular gap.
We examined the relevance of I SOC activation in the pulmonary circulation. Thapsigargin increased lung perme- 14, 15 Current-voltage relationships were recorded 3 to 5 minutes after break-in. Two hundred-millisecond pulses were applied every 3 seconds, from Ϫ100 to ϩ60 mV, with 20-mV increments; the holding potential was 0 mV. In PAECs, thapsigargin (1 mol/L) application through the patch pipette activated a small inward Ca 2ϩ current characteristic of I SOC . E, However, in PMVECs, thapsigargin did not activate I SOC , indicating the microvascular cells normally lack this Ca 2ϩ -selective current.
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ability approximately 3-fold, estimated by filtration coefficient ( Figure 7B ). Lung perfusion casts revealed prominent endothelial cell leak sites in extra-alveolar vessels, but evidence for increased permeability was not resolved in capillary segments ( Figure 7C ). Rolipram pretreatment decreased the thapsigargin-induced rise in permeability by nearly 50%. However, whereas rolipram decreased gap formation in extra-alveolar vessels, it increased permeability across capillary segments ( Figure 7D ). Thus, the net effect of the rolipram/thapsigargin treatment was to diminish leak sites in extra-alveolar vessels and to open new leak sites in the microcirculation, consistent with a role for I SOC activation in formation of interendothelial cell gap formation.
Discussion
Thapsigargin elevates [Ca 2ϩ ] i by simultaneously activating multiple SOC entry pathways. Both Ca 2ϩ -selective and nonselective cation entry pathways can be discriminated electrophysiologically, 13 but commonly the molecular basis of the channel that underlies this current and its relation to endothelial cell barrier function is poorly understood. Our present studies used different endothelial cell phenotypes to provide the first direct evidence that I SOC activation is sufficient to increase endothelial cell permeability.
Historically endothelial cells from conduit origins, eg, aorta and pulmonary artery, have been used as models for endothelial cell function. However, it is now clear that endothelial cells along the vascular tree are phenotypically distinct based on environmental and epigenetic control of their behavior, 19 including dynamic regulation of Ca 2ϩ transitions. 1, 18, 21, 35, 36 Thapsigargin activates a larger SOC entry response in PAECs than in PMVECs, although the mechanism for this observation is not clear. To discern the SOC entry pathways in PAECs and PMVECs, divalent cation entry was examined in intact cells. ] specifically controlled nitric oxide production and PKC␤ translocation, without altering PLA 2 activation. Our group has similarly shown that Ca 2ϩ transitions through endothelial cell "leak" channels inhibit basal cAMP production without dramatically altering global [Ca 2ϩ ] i . 34 Thus, it is not surprising that the activation of a small, Ca 2ϩ -selective current impacts membrane events without a change in bulk cytosolic function.
Although rolipram revealed the I SOC in PMVECs, it inhibited the thapsigargin-induced current in PAECs, allowing us to use rolipram as a tool to examine the importance of this current in controlling endothelial barrier function. In both cell types, the appearance of I SOC was required for thapsigargin to disrupt junctional apposition and decrease barrier function. However, this phenomenon was most pronounced in the intact lung, where rolipram treatment "shifted" the Figure 6 . PMVECs express TRPC4 and can be induced to activate I SOC . A, PMVEC monolayers were lysed, and the membrane skeleton extracted using Triton-X 100 with 100 mmol/L potassium iodide (KI). Immunoblot analysis of Triton-X insoluble (P) and soluble (S) fractions revealed TRPC4 (approximately 110 kDa) was located predominately in the S fraction. TRPC4 was found with protein 4.1 (approximately 110 kDa) and actin (approximately 43 kDa) (data not shown). B, Single cells were incubated with the type 4 phosphodiesterase inhibitor, rolipram, and a whole-cell voltage clamp configuration established as described elsewhere. 14, 15 Two hundred-millisecond pulses were applied every 3 seconds, from Ϫ100 to ϩ60 mV, with 20-mV increments; the holding potential was 0 mV. Whereas thapsigargin (TG; 1 mol/L) alone did not activate I SOC , rolipram (10 mol/L) pretreatment revealed I SOC activation. C, In contrast, thapsigargin (1 mol/L) was sufficient to activate I SOC in PAECs, whereas rolipram (10 mol/L) pretreatment abolished the current. and after (0.69Ϯ0.12 mL/min/cmH 2 O per 100g) thapsigargin (100 nmol/L) application. Venous pressure was then raised by Ϸ8 cmH 2 O from baseline, and a prepolymerized methyl methacrylate solution was circulated as described (see Materials and Methods). SEM of vascular casts reveals that thapsigargin induces leak sites in extra-alveolar blood vessels, and not in capillary segments. Data are representative of results from 4 separate experiments. Arrows denotes sites where the casting material exits the circulation. D, Rolipram (10 mol/L) pretreatment decreased the Kf response to thapsigargin (100 nmol/L; 0.45Ϯ0.12 mL/min/cmH 2 O per 100g; nϭ3). After final Kf measurements, lung corrosion casts were generated and examined by SEM as described in C. Rolipram/thapsigargin-treated lungs exhibited a decrease in extra-alveolar leak sites and a striking increase in permeability across capillary segments. Arrows denote sites where the casting material exits the circulation.
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thapsigargin-induced leak site from extra-alveolar vessels to capillary segments, in accordance with site-specific I SOC activation. Thus, rolipram desensitized extra-alveolar endothelium, and sensitized the alveolar endothelium, to Ca 2ϩ transitions through I SOC . The mechanisms responsible for these discrete rolipram actions are unknown. Rolipram increases cAMP concentrations in both cell types, although to a greater extent in PMVECs. 7, 18, 33 PMVECs exhibit a high cAMP turnover rate due to high membrane-associated phosphodiesterase 4 activity. 33 Phosphodiesterase activity importantly targets cAMP to effector molecules and fulfills a central role in achieving the threshold concentrations that are necessary to activate appropriate PKA and Epac molecules. 41 Although rises in membrane cAMP protect the microvascular endothelial cell barrier, 18 cAMP fluxes occurring outside this domain disrupt the endothelial cell barrier. 22 Thus, although speculative, rolipram may allow cAMP to escape its membrane domain in PMVECs and, when combined with I SOC activation that reduces membrane cAMP, result in loss of cell-cell apposition. Future studies will be required to examine how the rolipram and thapsigargin treatments discretely control [Ca 2ϩ ] and cAMP pools to regulate PMVEC barrier function.
In conclusion, we have demonstrated that PAECs and PMVECs possess different signaling pathways that control their SOC entries. Whereas thapsigargin activates I SOC in PAECs, it does not typically activate I SOC in PMVECs. However, the phosphodiesterase 4 inhibitor, rolipram, reveals the thapsigargin-activated I SOC in PMVECs and, most importantly, sensitizes alveolar endothelium to Ca 2ϩ transitions that lead to pulmonary edema. These results must be considered as potential complications to the clinical utility of rolipram and related phosphodiesterase inhibitors. 42, 43 
